| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE17 SPDYE10 ATG13 CIR1 SPDYE18 SPDYE12 STRIP1 RHOA RHOC SPDYE11 SPDYE15 CLTC SPDYE8 SPDYE21 RIMS1 SPDYE5 CTNND1 AKAP1 BECN1 TRIB1 BANK1 KIF11 SPDYE14 | 1.96e-07 | 873 | 152 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | SPDYE17 SPDYE10 ATG13 CIR1 SPDYE18 SPDYE12 STRIP1 RHOA RHOC SPDYE11 SPDYE15 CLTC SPDYE8 SPDYE21 RIMS1 SPDYE5 CTNND1 AKAP1 BECN1 TRIB1 BANK1 KIF11 SPDYE14 | 1.20e-06 | 969 | 152 | 23 | GO:0019900 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.79e-06 | 187 | 138 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | epiboly involved in wound healing | 1.37e-05 | 46 | 138 | 5 | GO:0090505 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of cells | 1.37e-05 | 46 | 138 | 5 | GO:0044319 | |
| GeneOntologyBiologicalProcess | epiboly | 1.53e-05 | 47 | 138 | 5 | GO:0090504 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell migration | 4.44e-05 | 2 | 138 | 2 | GO:1902766 | |
| GeneOntologyCellularComponent | postsynaptic specialization | RPLP0 GOPC MAP1A CAST PTPRT MACF1 PLEKHA5 RIMS1 CTNND1 AKAP1 RPL5 KCNT1 TMEM240 KPNA2 | 8.08e-06 | 503 | 141 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | RPLP0 GOPC MAP1A CAST PTPRT MACF1 PLEKHA5 RIMS1 CTNND1 RPL5 KCNT1 TMEM240 KPNA2 | 1.19e-05 | 451 | 141 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | RPLP0 GOPC MAP1A CAST PTPRT NECTIN1 MACF1 PLEKHA5 RIMS1 CTNND1 RPL5 KCNT1 TMEM240 KPNA2 | 1.25e-05 | 523 | 141 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | postsynapse | RPLP0 GOPC MAP1A CAST DOCK10 ITGB4 PTPRT RHOA CLTC MACF1 PLEKHA5 RIMS1 CTNND1 AKAP1 CAPRIN1 RPL5 KCNT1 SEZ6L TMEM240 KPNA2 | 1.67e-05 | 1018 | 141 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | asymmetric synapse | RPLP0 GOPC MAP1A CAST PTPRT MACF1 PLEKHA5 RIMS1 CTNND1 RPL5 KCNT1 TMEM240 KPNA2 | 2.15e-05 | 477 | 141 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | synaptic membrane | FCHO2 GRM8 ITGB4 PTPRT CNTN6 NECTIN1 CLTC RIMS1 AKAP1 KCNT1 SEZ6L TMEM240 | 6.02e-04 | 583 | 141 | 12 | GO:0097060 |
| Domain | Calx_beta | 2.34e-05 | 8 | 142 | 3 | SM00237 | |
| Domain | Calx_beta | 3.50e-05 | 9 | 142 | 3 | IPR003644 | |
| Domain | Calx-beta | 3.50e-05 | 9 | 142 | 3 | PF03160 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.75e-06 | 5 | 93 | 3 | MM15221 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 9.54e-06 | 7 | 93 | 3 | MM15217 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS | 2.27e-05 | 9 | 93 | 3 | M27551 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 4.41e-05 | 11 | 93 | 3 | MM15046 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.19e-04 | 15 | 93 | 3 | MM15037 | |
| Pathway | WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY | 1.97e-04 | 44 | 93 | 4 | M39602 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 2.08e-04 | 129 | 93 | 6 | M39693 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.49e-04 | 19 | 93 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 2.49e-04 | 19 | 93 | 3 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.92e-04 | 20 | 93 | 3 | M18415 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.50e-04 | 51 | 93 | 4 | MM14967 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 4.47e-04 | 23 | 93 | 3 | MM15216 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 5.09e-04 | 24 | 93 | 3 | M2243 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 EXOSC9 SMARCA5 RPLP0 DSG2 NPEPPS POLE PSMC3 RFC1 ZNF768 PRDM2 EFTUD2 RHOA PHF2 IPO9 MAPK15 RUVBL1 SUPT6H CLTC DNAJC9 MTR CPSF1 BOD1L1 CTNND1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 4.91e-12 | 1425 | 153 | 29 | 30948266 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EXOSC9 CAST PSMC3 KIF4A RREB1 PDCD4 EFTUD2 RUVBL1 CLTC BOD1L1 PALLD SF3B2 KIF11 KPNA2 | 2.88e-10 | 332 | 153 | 14 | 32786267 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EXOSC9 SMARCA5 RPLP0 USP24 CAST PSMC3 KIF4A RFC1 BIRC6 PDCD4 EFTUD2 CSDE1 RUVBL1 SUPT6H AFG3L2 ASPH CLTC DNAJC9 MACF1 CTNND1 CAPRIN1 RPL5 PALLD SF3B2 KIF11 KPNA2 | 6.41e-10 | 1415 | 153 | 26 | 28515276 |
| Pubmed | SMARCA5 RPLP0 NPEPPS POLE USP24 PSMC3 KIF4A RFC1 BIRC6 TASOR2 CSDE1 SUPT6H CLTC CPSF1 MACF1 CAPRIN1 RPL5 SF3B2 | 7.39e-10 | 653 | 153 | 18 | 22586326 | |
| Pubmed | SMARCA5 GOPC MAP1A DSG2 RREB1 ZNF768 TFDP1 ITIH4 PHF2 GTPBP2 MLH3 ZFHX4 SH3TC1 MTUS1 PCSK6 AFG3L2 BRD9 MTR MACF1 CRYBG3 PDZRN3 AGTPBP1 SEZ6L | 8.04e-10 | 1116 | 153 | 23 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SMARCA5 RPLP0 MAP1A DSG2 RNF113A CAST KIF4A RFC1 PDCD4 EFTUD2 CSDE1 RUVBL1 AFG3L2 MACF1 BOD1L1 CTNND1 AKAP1 RPL5 PALLD SF3B2 KIF11 | 1.02e-09 | 934 | 153 | 21 | 33916271 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EXOSC9 SMARCA5 RPLP0 DSG2 RFC1 ITGB4 ZNF768 PDCD4 TASOR2 EFTUD2 CSDE1 RUVBL1 AFG3L2 ASPH CLTC DNAJC9 CPSF1 PLEKHA5 CTNND1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 1.50e-09 | 1257 | 153 | 24 | 36526897 |
| Pubmed | COL12A1 RPLP0 GOPC DSG2 USP24 CIR1 PSMC3 RFC1 LARS2 BIRC6 RHOA RHOB CSDE1 AFG3L2 ASPH CLTC MACF1 BOD1L1 MRPL38 AKAP1 CAPRIN1 PALLD KIF11 KPNA2 | 2.77e-09 | 1297 | 153 | 24 | 33545068 | |
| Pubmed | SMARCA5 RPLP0 EFTUD2 PHF2 RUVBL1 SUPT6H CLTC BOD1L1 CAPRIN1 PALLD SF3B2 MED13 | 3.41e-09 | 272 | 153 | 12 | 31010829 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SMARCA5 NPEPPS POLE DOCK10 PSMC3 KIF4A RFC1 BIRC6 EFTUD2 CSDE1 IPO9 RUVBL1 AFG3L2 ASPH CLTC CPSF1 MACF1 PLEKHA5 CTNND1 CAPRIN1 RPL5 PALLD SF3B2 KIF11 | 6.27e-09 | 1353 | 153 | 24 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SMARCA5 RPLP0 USP24 CAST RFC1 RREB1 ZNF768 PRDM2 STRIP1 EFTUD2 ASPH CLTC CPSF1 RIMS1 AKAP1 SF3B2 MED13 AGTPBP1 | 1.04e-08 | 774 | 153 | 18 | 15302935 |
| Pubmed | FRAS1 POLE DOCK10 SBNO2 CSDE1 GTPBP2 AFG3L2 ASPH MTR PLEKHA5 IFT122 EIF2AK4 CRYBG3 RPL5 PALLD SF3B2 | 3.32e-08 | 650 | 153 | 16 | 38777146 | |
| Pubmed | FRAS1 ATG13 DOCK10 ATP9A STRIP1 MFAP3L CSDE1 ZFR2 CLTC MACF1 BOD1L1 AGTPBP1 SEZ6L | 3.48e-08 | 407 | 153 | 13 | 12693553 | |
| Pubmed | EXOSC9 SMARCA5 DSG2 NPEPPS RFC1 CSDE1 RHOC PHF2 C3P1 IPO9 RUVBL1 TCHHL1 PCSK6 ASPH CLTC DNAJC9 CPSF1 EIF2AK4 CTNND1 MUC5AC CAPRIN1 SF3B2 AGTPBP1 | 3.73e-08 | 1371 | 153 | 23 | 36244648 | |
| Pubmed | FRAS1 RPLP0 GOPC DSG2 POLE TFDP1 EFTUD2 SUPT6H AFG3L2 ASPH CLTC DNAJC9 MTR MACF1 PLEKHA5 MRPL38 IFT122 CRYBG3 CTNND1 AKAP1 CAPRIN1 RPL5 SF3B2 AGTPBP1 | 3.77e-08 | 1487 | 153 | 24 | 33957083 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EXOSC9 SMARCA5 POLE KIF4A RFC1 BIRC6 ZNF768 CSDE1 RUVBL1 ASPH DNAJC9 MACF1 AKAP1 BECN1 RPL5 AGTPBP1 KPNA2 | 4.72e-08 | 759 | 153 | 17 | 35915203 |
| Pubmed | COL12A1 PSMC3 KMT2E DYSF BIRC6 XIRP2 SUPT6H AFG3L2 CLTC MACF1 AKAP1 PALLD MED13 AGTPBP1 | 4.84e-08 | 497 | 153 | 14 | 23414517 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 4.89e-08 | 163 | 153 | 9 | 22113938 | |
| Pubmed | RPLP0 GOPC RFC1 IPO9 RUVBL1 AFG3L2 ASPH CLTC DNAJC9 MACF1 EIF2AK4 CTNND1 BECN1 RPL5 SF3B2 | 7.62e-08 | 601 | 153 | 15 | 33658012 | |
| Pubmed | RhoA, RhoB and RhoC have different roles in cancer cell migration. | 8.35e-08 | 3 | 153 | 3 | 23488932 | |
| Pubmed | A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. | 8.35e-08 | 3 | 153 | 3 | 12939257 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 29500478 | ||
| Pubmed | RhoA, RhoB and RhoC differentially regulate endothelial barrier function. | 8.35e-08 | 3 | 153 | 3 | 28949796 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19477269 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 22673745 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 26741994 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 15642170 | ||
| Pubmed | Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. | 8.35e-08 | 3 | 153 | 3 | 27147504 | |
| Pubmed | DNHD1 EFCAB5 SMARCA5 RPLP0 RFC1 EFTUD2 KIAA1549L CLTC MACF1 SF3B2 | 9.71e-08 | 234 | 153 | 10 | 36243803 | |
| Pubmed | RPLP0 USP24 RFC1 PDCD4 EFTUD2 RUVBL1 SUPT6H ASPH CLTC CPSF1 CAPRIN1 RPL5 PALLD SF3B2 KPNA2 | 1.03e-07 | 615 | 153 | 15 | 31048545 | |
| Pubmed | RPLP0 DSG2 USP24 FCHO2 CSDE1 RUVBL1 AFG3L2 MACF1 PLEKHA5 BOD1L1 CRYBG3 CTNND1 RPL5 PALLD SF3B2 KPNA2 | 1.06e-07 | 708 | 153 | 16 | 39231216 | |
| Pubmed | RPLP0 GOPC CAST PSMC3 RFC1 PDCD4 CSDE1 IPO9 RUVBL1 CLTC MACF1 RPL5 PALLD SF3B2 | 1.28e-07 | 538 | 153 | 14 | 28524877 | |
| Pubmed | EXOSC9 RPLP0 PDCD4 TASOR2 EFTUD2 CSDE1 RUVBL1 CLTC CPSF1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 1.70e-07 | 551 | 153 | 14 | 34728620 | |
| Pubmed | RGPD2 NHSL2 NPEPPS KIF4A ITIH4 STRIP1 EFTUD2 RHOC CLTC DNAJC9 MACF1 PLEKHA5 RIMS1 CTNND1 CAPRIN1 KCNT1 KIF11 TMEM240 | 2.73e-07 | 963 | 153 | 18 | 28671696 | |
| Pubmed | SMARCA5 RPLP0 PSMC3 RFC1 ZNF768 PHF2 IPO9 CLTC DNAJC9 BOD1L1 CAPRIN1 | 2.93e-07 | 333 | 153 | 11 | 36779763 | |
| Pubmed | SMARCA5 NPEPPS PSMC3 EFTUD2 CSDE1 RUVBL1 CLTC CAPRIN1 RPL5 PALLD SF3B2 KIF11 KPNA2 | 3.22e-07 | 494 | 153 | 13 | 26831064 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SMARCA5 POLE USP24 PSMC3 KIF4A EFTUD2 IPO9 RUVBL1 CPSF1 MACF1 CTNND1 SF3B2 KIF11 KPNA2 | 3.29e-07 | 582 | 153 | 14 | 20467437 |
| Pubmed | Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. | 3.33e-07 | 4 | 153 | 3 | 10559899 | |
| Pubmed | XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. | 3.33e-07 | 4 | 153 | 3 | 12221096 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 8662891 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 22992742 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.21e-07 | 153 | 153 | 8 | 26365490 | |
| Pubmed | SMARCA5 RPLP0 EFTUD2 CSDE1 RUVBL1 CLTC DNAJC9 MRPL38 RPL5 SF3B2 KIF11 KPNA2 | 4.45e-07 | 425 | 153 | 12 | 21081503 | |
| Pubmed | SMARCA5 RPLP0 NPEPPS PSMC3 KIF4A RFC1 PDCD4 EFTUD2 RHOA IPO9 RUVBL1 AFG3L2 CLTC CPSF1 CTNND1 CAPRIN1 RPL5 SF3B2 MED13 KPNA2 | 6.37e-07 | 1247 | 153 | 20 | 27684187 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | LRRC34 CDH23 ATP10A LINS1 ZFHX4 ADAMTS18 MACF1 PLEKHA5 RPL5 PALLD KIF11 | 6.50e-07 | 361 | 153 | 11 | 26167880 |
| Pubmed | EXOSC9 RPLP0 RFC1 ZNF768 EFTUD2 CSDE1 RUVBL1 ASPH DNAJC9 CPSF1 MRPL38 CAPRIN1 RPL5 SF3B2 KPNA2 | 6.68e-07 | 713 | 153 | 15 | 29802200 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EXOSC9 RPLP0 NPEPPS CAST PSMC3 RFC1 EFTUD2 RHOA RHOB IPO9 RUVBL1 CLTC DNAJC9 MACF1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 7.91e-07 | 1149 | 153 | 19 | 35446349 |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 8617235 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 15093731 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 8543060 | ||
| Pubmed | GOPC PSMC3 FCHO2 BIRC6 PTPRT PHF2 IPO9 MTUS1 AFG3L2 CLTC KIAA1328 CPSF1 UBR3 EIF2AK4 CRYBG3 CTNND1 AGTPBP1 KPNA2 | 9.35e-07 | 1049 | 153 | 18 | 27880917 | |
| Pubmed | SMARCA5 DSG2 USP24 PSMC3 EFTUD2 CSDE1 IPO9 RUVBL1 SUPT6H CLTC RPL5 SF3B2 KIF11 KPNA2 | 9.79e-07 | 638 | 153 | 14 | 33239621 | |
| Pubmed | SMARCA5 DSG2 USP24 CAST KIF4A CSDE1 RUVBL1 CLTC PLEKHA5 BOD1L1 CTNND1 PALLD KPNA2 | 1.05e-06 | 549 | 153 | 13 | 38280479 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SMARCA5 RPLP0 USP24 PSMC3 GMEB2 RFC1 RREB1 PDCD4 ITIH4 EFTUD2 CSDE1 PHF2 IPO9 RUVBL1 AFG3L2 CLTC BRD9 RPL5 SF3B2 KPNA2 | 1.49e-06 | 1318 | 153 | 20 | 30463901 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.56e-06 | 182 | 153 | 8 | 30711629 | |
| Pubmed | Small GTP-binding proteins and the regulation of the actin cytoskeleton. | 1.65e-06 | 6 | 153 | 3 | 7888179 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 9438836 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 19286565 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | EXOSC9 SMARCA5 RPLP0 PSMC3 KIF4A RFC1 EFTUD2 RUVBL1 SUPT6H CLTC DNAJC9 BOD1L1 CTNND1 CAPRIN1 RPL5 SF3B2 KPNA2 | 1.87e-06 | 989 | 153 | 17 | 36424410 |
| Pubmed | GOPC NPEPPS RNF113A PSMC3 KIF4A GMEB2 RFC1 RREB1 PRDM2 RHOA CSDE1 PHF2 CLTC BRD9 DNAJC9 CAPRIN1 RPL5 KIF11 | 1.90e-06 | 1103 | 153 | 18 | 34189442 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SMARCA5 RPLP0 POLE RFC1 RREB1 TFDP1 EFTUD2 RUVBL1 ZFHX4 ZIC5 CLTC SF3B2 KPNA2 | 2.04e-06 | 583 | 153 | 13 | 29844126 |
| Pubmed | PRUNE2 BIRC6 ATP10A EFTUD2 PHF2 IPO9 UBR3 MACF1 ANKRD24 PALLD PDZRN3 PDZRN4 | 2.09e-06 | 493 | 153 | 12 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 NPEPPS ATG13 CAST ATP10A SBNO2 TASOR2 CSDE1 PHF2 SH3TC1 SUPT6H ASPH KIAA1328 MACF1 BOD1L1 ANKRD24 IFT122 EIF2AK4 RIMS1 MME CTNND1 | 2.53e-06 | 1489 | 153 | 21 | 28611215 |
| Pubmed | RGPD2 USP24 RREB1 BIRC6 TFDP1 PRDM2 ZFHX4 PLEKHA5 CRYBG3 AKAP1 KIF11 | 2.69e-06 | 418 | 153 | 11 | 34709266 | |
| Pubmed | RHO binding to FAM65A regulates Golgi reorientation during cell migration. | 2.88e-06 | 7 | 153 | 3 | 27807006 | |
| Pubmed | RGPD2 RPLP0 GOPC MAP1A USP24 BIRC6 CSDE1 RUVBL1 NECTIN1 AFG3L2 CLTC UBR3 MACF1 RIMS1 CRYBG3 CTNND1 CAPRIN1 RPL5 | 2.97e-06 | 1139 | 153 | 18 | 36417873 | |
| Pubmed | SMARCA5 DSG2 NPEPPS POLE TFDP1 RHOA RHOC AFG3L2 MTR CPSF1 CTNND1 CAPRIN1 RPL5 | 3.11e-06 | 606 | 153 | 13 | 36538041 | |
| Pubmed | MAP1A NPEPPS ATG13 STK11 XIRP2 AFG3L2 ASPH CLTC MRPL38 CTNND1 BECN1 | 4.11e-06 | 437 | 153 | 11 | 20562859 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.21e-06 | 208 | 153 | 8 | 33230847 | |
| Pubmed | RPLP0 NPEPPS POLE EFTUD2 CSDE1 RUVBL1 AFG3L2 CLTC DNAJC9 MTR CAPRIN1 RPL5 SF3B2 KPNA2 | 4.30e-06 | 725 | 153 | 14 | 27025967 | |
| Pubmed | 4.36e-06 | 209 | 153 | 8 | 36779422 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | EXOSC9 SMARCA5 RPLP0 RUVBL1 SUPT6H CLTC DNAJC9 CTNND1 CAPRIN1 RPL5 KPNA2 | 4.38e-06 | 440 | 153 | 11 | 34244565 |
| Pubmed | SMARCA5 RPLP0 KIF4A RFC1 EFTUD2 CSDE1 CLTC CAPRIN1 RPL5 KIF11 KPNA2 | 4.48e-06 | 441 | 153 | 11 | 31239290 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 4.68e-06 | 211 | 153 | 8 | 17314511 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EXOSC9 SMARCA5 RPLP0 CAST KIF4A RFC1 RREB1 TASOR2 EFTUD2 PHF2 RUVBL1 CLTC BRD9 BOD1L1 RPL5 SF3B2 | 5.22e-06 | 954 | 153 | 16 | 36373674 |
| Pubmed | EXOSC9 SMARCA5 RPLP0 DSG2 RFC1 EFTUD2 RUVBL1 ASPH DNAJC9 CPSF1 CTNND1 CAPRIN1 RPL5 SF3B2 KPNA2 | 5.48e-06 | 847 | 153 | 15 | 35850772 | |
| Pubmed | PSMC3 ZNF768 PDCD4 TFDP1 RUVBL1 AFG3L2 ASPH PLEKHA5 MRPL38 RPL5 AGTPBP1 KPNA2 | 6.02e-06 | 547 | 153 | 12 | 37267103 | |
| Pubmed | 6.25e-06 | 102 | 153 | 6 | 9734811 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD2 RPLP0 NPEPPS CAST PSMC3 ITGB4 IPO9 RUVBL1 CLTC UBR3 RPL5 SF3B2 KPNA2 | 6.29e-06 | 647 | 153 | 13 | 26618866 |
| Pubmed | 6.79e-06 | 222 | 153 | 8 | 35941108 | ||
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 15151987 | ||
| Pubmed | EXOSC9 SMARCA5 RPLP0 MAP1A PSMC3 RFC1 ZNF768 EFTUD2 CSDE1 IPO9 RUVBL1 AFG3L2 CLTC DNAJC9 CTNND1 CAPRIN1 RPL5 SF3B2 KPNA2 | 6.97e-06 | 1335 | 153 | 19 | 29229926 | |
| Pubmed | 7.02e-06 | 223 | 153 | 8 | 33731348 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 7.74e-06 | 226 | 153 | 8 | 25900982 | |
| Pubmed | SMARCA5 DSG2 PSMC3 KIF4A EFTUD2 RUVBL1 CLTC CPSF1 MACF1 CTNND1 CAPRIN1 RPL5 KPNA2 | 7.78e-06 | 660 | 153 | 13 | 32780723 | |
| Pubmed | NPEPPS EFTUD2 CSDE1 RUVBL1 ASPH CLTC CPSF1 CTNND1 CAPRIN1 SF3B2 KPNA2 | 7.99e-06 | 469 | 153 | 11 | 37314180 | |
| Pubmed | RPLP0 GOPC DSG2 RNF113A PSMC3 EFTUD2 CSDE1 RUVBL1 PCSK6 ASPH DNAJC9 PLEKHA5 CTNND1 AKAP1 CAPRIN1 PALLD | 1.02e-05 | 1007 | 153 | 16 | 34597346 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RPLP0 RFC1 EFTUD2 ASPH CLTC DNAJC9 PLEKHA5 CTNND1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 1.03e-05 | 678 | 153 | 13 | 30209976 |
| Pubmed | 1.07e-05 | 112 | 153 | 6 | 28416769 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | EXOSC9 RPLP0 PSMC3 RFC1 EFTUD2 AFG3L2 ASPH DNAJC9 CAPRIN1 RPL5 KPNA2 | 1.11e-05 | 486 | 153 | 11 | 30940648 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD2 RPLP0 NPEPPS POLE PSMC3 RFC1 BIRC6 EFTUD2 CSDE1 RUVBL1 AFG3L2 CLTC MTR CPSF1 CTNND1 RPL5 SF3B2 KPNA2 | 1.14e-05 | 1257 | 153 | 18 | 37317656 |
| Pubmed | GOPC PSMC3 CSDE1 RUVBL1 BOD1L1 CAPRIN1 PALLD SF3B2 KIF11 KPNA2 | 1.18e-05 | 399 | 153 | 10 | 35987950 | |
| Pubmed | 1.23e-05 | 241 | 153 | 8 | 23125841 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EXOSC9 SMARCA5 RPLP0 DSG2 NPEPPS EFTUD2 RUVBL1 SUPT6H AFG3L2 CLTC CPSF1 MACF1 CTNND1 RPL5 SF3B2 KPNA2 | 1.26e-05 | 1024 | 153 | 16 | 24711643 |
| Pubmed | EFCAB5 RPLP0 RFC1 EFTUD2 CSDE1 RUVBL1 ASPH CLTC BOD1L1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 1.48e-05 | 809 | 153 | 14 | 32129710 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | RNF113A PSMC3 TFDP1 PHF2 STK11 RUVBL1 ZIC5 CLTC CPSF1 PLEKHA5 EIF2AK4 CTNND1 MERTK MED13 KPNA2 | 1.49e-05 | 922 | 153 | 15 | 27609421 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.53e-05 | 179 | 153 | 7 | 36261009 | |
| Pubmed | SMARCA5 USP24 KIF4A FCHO2 RFC1 ITGB4 PDCD4 STRIP1 PLEKHA5 PALLD KPNA2 | 1.53e-05 | 503 | 153 | 11 | 16964243 | |
| Pubmed | SMARCA5 RPLP0 RNF113A PSMC3 KIF4A RUVBL1 CLTC CPSF1 BOD1L1 SF3B2 KPNA2 | 1.62e-05 | 506 | 153 | 11 | 30890647 | |
| Pubmed | LRRC8C RPLP0 DOCK10 PSMC3 KIF4A BIRC6 EFTUD2 IPO9 CLTC PLEKHA5 IFT122 AKAP1 CAPRIN1 RPL5 MED13 KIF11 KPNA2 | 1.65e-05 | 1168 | 153 | 17 | 19946888 | |
| Interaction | KCNA3 interactions | DNHD1 RPLP0 DSG2 USP24 DOCK10 FCHO2 PRDM2 CSDE1 RUVBL1 AFG3L2 MACF1 PLEKHA5 BOD1L1 EIF2AK4 RIMS1 CRYBG3 CTNND1 RPL5 PALLD SF3B2 KIF11 KPNA2 | 2.20e-07 | 871 | 143 | 22 | int:KCNA3 |
| Interaction | CIT interactions | EXOSC9 SMARCA5 RPLP0 DSG2 NPEPPS PSMC3 RREB1 BIRC6 ITIH4 EFTUD2 RHOA RHOB RHOC PHF2 RUVBL1 SUPT6H ASPH CLTC DNAJC9 CPSF1 MACF1 BOD1L1 CTNND1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 1.02e-06 | 1450 | 143 | 28 | int:CIT |
| Interaction | ECT2 interactions | EXOSC9 SMARCA5 RPLP0 DSG2 NPEPPS CIR1 EFTUD2 RHOA RHOB RHOC IPO9 RUVBL1 CLTC BRD9 MACF1 BOD1L1 MME CAPRIN1 RPL5 SF3B2 KPNA2 | 1.22e-06 | 887 | 143 | 21 | int:ECT2 |
| Interaction | WWP2 interactions | RPLP0 USP24 RFC1 PDCD4 EFTUD2 RHOA RHOB CSDE1 RHOC RUVBL1 SUPT6H ASPH CLTC SCNN1G CPSF1 CAPRIN1 RPL5 PALLD SF3B2 KPNA2 | 2.06e-06 | 840 | 143 | 20 | int:WWP2 |
| Interaction | BIRC3 interactions | DNHD1 EXOSC9 SMARCA5 RPLP0 DSG2 NPEPPS PSMC3 RFC1 PRDM2 EFTUD2 RHOA PHF2 IPO9 MAPK15 RUVBL1 SUPT6H CLTC DNAJC9 CPSF1 CTNND1 BECN1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 2.25e-06 | 1334 | 143 | 26 | int:BIRC3 |
| Interaction | GRM2 interactions | SMARCA5 RPLP0 NPEPPS PSMC3 RFC1 LARS2 ZNF768 PHF2 IPO9 CLTC DNAJC9 BOD1L1 CAPRIN1 | 3.35e-06 | 381 | 143 | 13 | int:GRM2 |
| Interaction | PFN1 interactions | MAP1A FCHO2 BIRC6 RHOA RHOB RHOC CLTC MTR MACF1 PLEKHA5 BOD1L1 CRYBG3 PALLD SF3B2 KIF11 | 3.48e-06 | 509 | 143 | 15 | int:PFN1 |
| Interaction | LYN interactions | PRUNE2 EXOSC9 DSG2 CDH23 FCHO2 EFTUD2 RHOA RHOB RHOC PHF2 AFG3L2 MACF1 CD72 PLEKHA5 MME CTNND1 RPL5 BANK1 | 3.57e-06 | 720 | 143 | 18 | int:LYN |
| Interaction | PTRH2 interactions | 4.46e-06 | 223 | 143 | 10 | int:PTRH2 | |
| Interaction | SUMO2 interactions | EXOSC9 CAST PSMC3 KIF4A RREB1 PDCD4 EFTUD2 RUVBL1 CLTC BOD1L1 CTNND1 MERTK PALLD SF3B2 KIF11 KPNA2 | 4.78e-06 | 591 | 143 | 16 | int:SUMO2 |
| Interaction | NAA40 interactions | SMARCA5 RPLP0 MAP1A DSG2 RNF113A CAST KIF4A RFC1 PDCD4 EFTUD2 CSDE1 RUVBL1 AFG3L2 MACF1 BOD1L1 CTNND1 AKAP1 RPL5 PALLD SF3B2 KIF11 | 5.62e-06 | 978 | 143 | 21 | int:NAA40 |
| Interaction | EFTUD2 interactions | EXOSC9 SMARCA5 RPLP0 USP24 CAST PSMC3 KIF4A RFC1 BIRC6 PDCD4 EFTUD2 CSDE1 RUVBL1 AFG3L2 ASPH CLTC DNAJC9 MACF1 CTNND1 CAPRIN1 RPL5 PALLD SF3B2 MED13 KIF11 KPNA2 | 9.98e-06 | 1449 | 143 | 26 | int:EFTUD2 |
| Interaction | DIRAS3 interactions | GOPC DSG2 PSMC3 FCHO2 RHOA AFG3L2 MACF1 PLEKHA5 CTNND1 BECN1 | 1.82e-05 | 262 | 143 | 10 | int:DIRAS3 |
| Interaction | OBSL1 interactions | PRUNE2 EXOSC9 SMARCA5 RPLP0 DSG2 RFC1 TASOR2 EFTUD2 RUVBL1 SUPT6H ASPH CLTC DNAJC9 CPSF1 MACF1 RPL5 SF3B2 AGTPBP1 KPNA2 | 2.14e-05 | 902 | 143 | 19 | int:OBSL1 |
| Interaction | SIRT7 interactions | RPLP0 NPEPPS POLE USP24 PSMC3 KIF4A RFC1 BIRC6 TASOR2 CSDE1 SUPT6H CLTC CPSF1 MACF1 CAPRIN1 RPL5 SF3B2 | 2.17e-05 | 744 | 143 | 17 | int:SIRT7 |
| Interaction | KIF23 interactions | SMARCA5 RPLP0 DSG2 PSMC3 RFC1 BIRC6 EFTUD2 RHOC STK11 RUVBL1 ASPH CLTC CPSF1 MACF1 MME CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 4.12e-05 | 1031 | 143 | 20 | int:KIF23 |
| Interaction | SIRT6 interactions | EXOSC9 SMARCA5 RPLP0 KIF4A TASOR2 EFTUD2 RUVBL1 SUPT6H CLTC DNAJC9 CTNND1 CAPRIN1 RPL5 PALLD KPNA2 | 4.13e-05 | 628 | 143 | 15 | int:SIRT6 |
| Interaction | FBXW7 interactions | COL12A1 RPLP0 GOPC HEMGN RFC1 IPO9 RUVBL1 SUPT6H AFG3L2 ASPH CLTC BRD9 DNAJC9 CPSF1 MACF1 EIF2AK4 CTNND1 BECN1 RPL5 SF3B2 MED13 KIF11 | 4.63e-05 | 1215 | 143 | 22 | int:FBXW7 |
| Interaction | SLK interactions | 4.97e-05 | 183 | 143 | 8 | int:SLK | |
| Interaction | GOLGA1 interactions | 4.97e-05 | 183 | 143 | 8 | int:GOLGA1 | |
| Interaction | LRRC8D interactions | 5.03e-05 | 29 | 143 | 4 | int:LRRC8D | |
| Interaction | ARHGEF1 interactions | 5.32e-05 | 136 | 143 | 7 | int:ARHGEF1 | |
| Interaction | KIF20A interactions | LRRC8C EXOSC9 SMARCA5 RPLP0 DSG2 ITIH4 EFTUD2 RHOB RUVBL1 SUPT6H CLTC CPSF1 MACF1 BOD1L1 CRYBG3 CTNND1 CAPRIN1 RPL5 SF3B2 KPNA2 | 5.45e-05 | 1052 | 143 | 20 | int:KIF20A |
| Interaction | LAMTOR1 interactions | GOPC DSG2 FCHO2 ATP9A RHOA RHOB RHOC STK11 RUVBL1 AFG3L2 CLTC MTR PLEKHA5 MME CRYBG3 CTNND1 | 5.54e-05 | 722 | 143 | 16 | int:LAMTOR1 |
| Interaction | CCDC8 interactions | SMARCA5 RPLP0 GOPC DSG2 NPEPPS EFTUD2 RHOA RHOB RUVBL1 AFG3L2 CLTC MACF1 CTNND1 RPL5 KPNA2 | 6.76e-05 | 656 | 143 | 15 | int:CCDC8 |
| Interaction | HECTD1 interactions | EXOSC9 SMARCA5 POLE KIF4A RFC1 BIRC6 ZNF768 PDCD4 EFTUD2 CSDE1 RUVBL1 ASPH DNAJC9 MACF1 AKAP1 BECN1 RPL5 AGTPBP1 KPNA2 | 6.93e-05 | 984 | 143 | 19 | int:HECTD1 |
| Interaction | SNRNP70 interactions | EXOSC9 SMARCA5 RPLP0 RNF113A RFC1 ZNF768 EFTUD2 CSDE1 GTPBP2 RUVBL1 ASPH DNAJC9 CPSF1 MRPL38 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 6.93e-05 | 984 | 143 | 19 | int:SNRNP70 |
| Interaction | TENM2 interactions | 7.34e-05 | 12 | 143 | 3 | int:TENM2 | |
| Interaction | ZNF330 interactions | EXOSC9 SMARCA5 POLE KIF4A RFC1 RREB1 ZNF768 PHF2 IPO9 SUPT6H RPL5 KPNA2 | 8.28e-05 | 446 | 143 | 12 | int:ZNF330 |
| Interaction | ARHGEF2 interactions | 9.09e-05 | 256 | 143 | 9 | int:ARHGEF2 | |
| Interaction | WDR5 interactions | SMARCA5 RPLP0 NPEPPS RNF113A PSMC3 TFDP1 EFTUD2 RHOA RHOC RUVBL1 ASPH CLTC BRD9 DNAJC9 MACF1 BOD1L1 CTNND1 CAPRIN1 RPL5 SF3B2 | 1.02e-04 | 1101 | 143 | 20 | int:WDR5 |
| Interaction | GRWD1 interactions | RNF113A RFC1 KMT2E EFTUD2 RHOA RUVBL1 AFG3L2 CLTC MERTK RPL5 SF3B2 | 1.09e-04 | 390 | 143 | 11 | int:GRWD1 |
| Interaction | TRIM66 interactions | 1.10e-04 | 205 | 143 | 8 | int:TRIM66 | |
| Interaction | ACTC1 interactions | SMARCA5 RPLP0 RNF113A PSMC3 KIF4A RHOA RHOB RHOC RUVBL1 CLTC BRD9 CPSF1 BOD1L1 SF3B2 KPNA2 | 1.26e-04 | 694 | 143 | 15 | int:ACTC1 |
| Interaction | PHLPP1 interactions | DSG2 FCHO2 CSDE1 RUVBL1 CLTC PLEKHA5 CTNND1 SF3B2 AGTPBP1 KIF11 | 1.36e-04 | 333 | 143 | 10 | int:PHLPP1 |
| Interaction | MSH6 interactions | 1.40e-04 | 271 | 143 | 9 | int:MSH6 | |
| Interaction | GSK3B interactions | RPLP0 MAP1A DSG2 NPEPPS CAST EFTUD2 CSDE1 STK11 MTUS1 CLTC MACF1 PLEKHA5 CRYBG3 CTNND1 MUC5AC CAPRIN1 PALLD | 1.45e-04 | 868 | 143 | 17 | int:GSK3B |
| Interaction | PPFIA1 interactions | 1.48e-04 | 214 | 143 | 8 | int:PPFIA1 | |
| Interaction | FLOT1 interactions | DSG2 RHOA RHOB RHOC RUVBL1 AFG3L2 MACF1 PLEKHA5 BOD1L1 MRPL38 CRYBG3 CTNND1 | 1.49e-04 | 475 | 143 | 12 | int:FLOT1 |
| Interaction | RIPOR2 interactions | 1.50e-04 | 15 | 143 | 3 | int:RIPOR2 | |
| Interaction | SMC4 interactions | 1.83e-04 | 281 | 143 | 9 | int:SMC4 | |
| Interaction | EPHA7 interactions | 1.88e-04 | 282 | 143 | 9 | int:EPHA7 | |
| Interaction | CTNNA1 interactions | 1.90e-04 | 347 | 143 | 10 | int:CTNNA1 | |
| Interaction | PPIA interactions | RPLP0 MAP1A RNF113A CAST FCHO2 RFC1 EFTUD2 RHOA RHOB CSDE1 RHOC MACF1 PLEKHA5 CRYBG3 CTNND1 CAPRIN1 KIF11 | 1.90e-04 | 888 | 143 | 17 | int:PPIA |
| Interaction | KPNA1 interactions | SMARCA5 GOPC EFTUD2 RHOA RHOB RHOC RUVBL1 ZFHX4 BOD1L1 KPNA2 | 2.08e-04 | 351 | 143 | 10 | int:KPNA1 |
| Interaction | OPTN interactions | RPLP0 LARS2 DYSF BIRC6 RHOA AFG3L2 CLTC AKAP1 BCL2L13 CAPRIN1 PALLD | 2.17e-04 | 422 | 143 | 11 | int:OPTN |
| Interaction | NECTIN3 interactions | 2.34e-04 | 78 | 143 | 5 | int:NECTIN3 | |
| Interaction | ATP1A1 interactions | SMARCA5 RNF113A PSMC3 EFTUD2 RHOA RHOB RHOC RUVBL1 ZFHX4 AFG3L2 ASPH CLTC AKAP1 | 2.35e-04 | 575 | 143 | 13 | int:ATP1A1 |
| Interaction | SRP9 interactions | EXOSC9 RPLP0 RFC1 PDCD4 EFTUD2 RHOA RHOB RHOC SUPT6H RPL5 SF3B2 | 2.40e-04 | 427 | 143 | 11 | int:SRP9 |
| Interaction | MTF1 interactions | 2.47e-04 | 123 | 143 | 6 | int:MTF1 | |
| Interaction | PARD3 interactions | 2.83e-04 | 298 | 143 | 9 | int:PARD3 | |
| Interaction | EIF6 interactions | RPLP0 NPEPPS RNF113A BIRC6 ITGB4 PDCD4 EFTUD2 CLTC DNAJC9 RPL5 | 2.84e-04 | 365 | 143 | 10 | int:EIF6 |
| Interaction | ERBB2 interactions | DSG2 PSMC3 ITGB4 PTPRT RHOB CSDE1 STK11 SUPT6H AFG3L2 CLTC PSMC3IP MERTK BECN1 | 2.96e-04 | 589 | 143 | 13 | int:ERBB2 |
| Interaction | YWHAH interactions | DSG2 NHSL2 ATG13 PSMC3 PDCD4 EFTUD2 IPO9 MTUS1 OTUD7A MACF1 PLEKHA5 BOD1L1 RIMS1 CRYBG3 CTNND1 AKAP1 BECN1 PALLD KIF11 | 2.98e-04 | 1102 | 143 | 19 | int:YWHAH |
| Interaction | STK11IP interactions | 3.12e-04 | 83 | 143 | 5 | int:STK11IP | |
| Interaction | HDAC1 interactions | SMARCA5 RNF113A USP24 PSMC3 KIF4A RFC1 RREB1 KMT2E BIRC6 TFDP1 EFTUD2 RUVBL1 ZFHX4 PLEKHA5 CRYBG3 AKAP1 CAPRIN1 SF3B2 KPNA2 | 3.19e-04 | 1108 | 143 | 19 | int:HDAC1 |
| Interaction | CYFIP1 interactions | 3.20e-04 | 303 | 143 | 9 | int:CYFIP1 | |
| Interaction | RPS23 interactions | RPLP0 ATG13 RNF113A CDH23 STRIP1 EFTUD2 MME CAPRIN1 RPL5 KIF11 | 3.38e-04 | 373 | 143 | 10 | int:RPS23 |
| Interaction | MARCKS interactions | GOPC DSG2 EFTUD2 RHOA RHOB RHOC RUVBL1 MACF1 PLEKHA5 CTNND1 AKAP1 RPL5 KPNA2 | 3.59e-04 | 601 | 143 | 13 | int:MARCKS |
| Interaction | CENPA interactions | 3.67e-04 | 377 | 143 | 10 | int:CENPA | |
| Interaction | NPAS1 interactions | 3.69e-04 | 245 | 143 | 8 | int:NPAS1 | |
| Interaction | KDM1A interactions | SMARCA5 RNF113A USP24 PSMC3 ZNF581 RREB1 BIRC6 TFDP1 PRDM2 EFTUD2 GTPBP2 ZFHX4 PLEKHA5 CRYBG3 AKAP1 SF3B2 KIF11 | 3.73e-04 | 941 | 143 | 17 | int:KDM1A |
| Interaction | HDLBP interactions | SMARCA5 DSG2 NPEPPS ATG13 RFC1 EFTUD2 CSDE1 PHF2 RUVBL1 PCSK6 CLTC CPSF1 EIF2AK4 SF3B2 AGTPBP1 KIF11 | 3.81e-04 | 855 | 143 | 16 | int:HDLBP |
| Interaction | USP7 interactions | DNHD1 EFCAB5 SMARCA5 TRPA1 RPLP0 NHSL2 RTL5 RNF113A USP24 DOCK10 RFC1 KMT2E IFNLR1 EFTUD2 KIAA1549L CLTC MACF1 AKAP1 BECN1 SF3B2 TMEM240 | 3.86e-04 | 1313 | 143 | 21 | int:USP7 |
| Interaction | BAP1 interactions | EXOSC9 RPLP0 GOPC NPEPPS CAST PSMC3 RFC1 EFTUD2 RHOA RHOB STK11 IPO9 RUVBL1 CLTC DNAJC9 MACF1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 3.90e-04 | 1314 | 143 | 21 | int:BAP1 |
| Interaction | NBR1 interactions | 3.91e-04 | 380 | 143 | 10 | int:NBR1 | |
| Interaction | CSNK1A1 interactions | NPEPPS RNF113A RFC1 EFTUD2 RHOB STK11 AFG3L2 CLTC CPSF1 KPNA2 | 3.99e-04 | 381 | 143 | 10 | int:CSNK1A1 |
| Interaction | BLTP1 interactions | 4.02e-04 | 49 | 143 | 4 | int:BLTP1 | |
| Interaction | HSF1 interactions | RPLP0 GOPC PSMC3 KIF4A ITIH4 EFTUD2 RUVBL1 SUPT6H CLTC CPSF1 PDZRN3 SF3B2 KPNA2 | 4.07e-04 | 609 | 143 | 13 | int:HSF1 |
| Interaction | CRIM1 interactions | 4.24e-04 | 21 | 143 | 3 | int:CRIM1 | |
| Interaction | MAU2 interactions | 4.24e-04 | 136 | 143 | 6 | int:MAU2 | |
| Interaction | UGCG interactions | 4.34e-04 | 50 | 143 | 4 | int:UGCG | |
| Interaction | VTI1B interactions | 4.35e-04 | 191 | 143 | 7 | int:VTI1B | |
| Interaction | FBXO22 interactions | DCHS2 SMARCA5 NPEPPS DYSF EFTUD2 STK11 XIRP2 AFG3L2 CPSF1 PLEKHA5 EIF2AK4 CTNND1 | 4.79e-04 | 540 | 143 | 12 | int:FBXO22 |
| Interaction | CXCR4 interactions | 4.82e-04 | 255 | 143 | 8 | int:CXCR4 | |
| Interaction | MOCS2 interactions | 4.88e-04 | 22 | 143 | 3 | int:MOCS2 | |
| Interaction | ST13 interactions | 4.92e-04 | 195 | 143 | 7 | int:ST13 | |
| Interaction | FAM83B interactions | 4.95e-04 | 140 | 143 | 6 | int:FAM83B | |
| Interaction | B2M interactions | 5.03e-04 | 92 | 143 | 5 | int:B2M | |
| Interaction | CEBPA interactions | GOPC NPEPPS RNF113A PSMC3 KIF4A GMEB2 RFC1 RREB1 PRDM2 RHOA CSDE1 PHF2 CLTC BRD9 DNAJC9 MACF1 CAPRIN1 RPL5 TRIB1 KIF11 | 5.09e-04 | 1245 | 143 | 20 | int:CEBPA |
| Interaction | BRCA1 interactions | DNHD1 SMARCA5 NPEPPS POLE PSMC3 RFC1 IFNLR1 EFTUD2 CSDE1 RUVBL1 SUPT6H CLTC BRD9 BECN1 CAPRIN1 RPL5 PALLD SF3B2 KIF11 KPNA2 | 5.30e-04 | 1249 | 143 | 20 | int:BRCA1 |
| Interaction | DDRGK1 interactions | EXOSC9 RPLP0 NPEPPS RFC1 ZNF768 EFTUD2 RHOA CSDE1 RHOC IPO9 RUVBL1 AFG3L2 ASPH CLTC DNAJC9 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 5.30e-04 | 1249 | 143 | 20 | int:DDRGK1 |
| Interaction | CLEC16A interactions | SMARCA5 DSG2 NPEPPS POLE TFDP1 RHOA RHOC AFG3L2 MTR CPSF1 CTNND1 CAPRIN1 RPL5 | 5.52e-04 | 629 | 143 | 13 | int:CLEC16A |
| Interaction | FBXW11 interactions | POLE LARS2 PDCD4 IFNLR1 STK11 CLTC MERTK RPL5 PALLD SF3B2 KPNA2 | 5.68e-04 | 473 | 143 | 11 | int:FBXW11 |
| Interaction | SLC16A1 interactions | 5.72e-04 | 200 | 143 | 7 | int:SLC16A1 | |
| Interaction | MST1R interactions | 5.72e-04 | 200 | 143 | 7 | int:MST1R | |
| Interaction | EPHA5 interactions | 5.74e-04 | 144 | 143 | 6 | int:EPHA5 | |
| Interaction | RAB23 interactions | 5.84e-04 | 54 | 143 | 4 | int:RAB23 | |
| Interaction | SCO1 interactions | 5.89e-04 | 201 | 143 | 7 | int:SCO1 | |
| Interaction | MYO1E interactions | 6.07e-04 | 202 | 143 | 7 | int:MYO1E | |
| Interaction | EPHA2 interactions | GOPC DSG2 CIR1 FCHO2 RHOA RHOB RHOC STK11 AFG3L2 CLTC MACF1 PLEKHA5 CTNND1 BECN1 | 6.08e-04 | 719 | 143 | 14 | int:EPHA2 |
| Interaction | NUP155 interactions | GOPC DSG2 EFTUD2 RHOA RHOB RHOC AFG3L2 CRYBG3 MERTK AKAP1 KPNA2 | 6.09e-04 | 477 | 143 | 11 | int:NUP155 |
| Interaction | BRD7 interactions | EXOSC9 RPLP0 USP24 PSMC3 RFC1 EFTUD2 AFG3L2 ASPH BRD9 DNAJC9 CAPRIN1 RPL5 KPNA2 | 6.21e-04 | 637 | 143 | 13 | int:BRD7 |
| Interaction | RSL1D1 interactions | RPLP0 RNF113A CAST EFTUD2 RHOA RHOB RHOC ZNF16 DNAJC9 RPL5 SF3B2 | 6.30e-04 | 479 | 143 | 11 | int:RSL1D1 |
| Interaction | FZR1 interactions | EXOSC9 RPLP0 CAST PSMC3 PCDHAC1 RFC1 EFTUD2 CSDE1 RHOC STK11 RUVBL1 PSMC3IP CPSF1 BECN1 CAPRIN1 RPL5 SF3B2 KIF11 KPNA2 | 6.36e-04 | 1172 | 143 | 19 | int:FZR1 |
| Interaction | FBL interactions | SMARCA5 RNF113A HEMGN RFC1 EFTUD2 RHOA CSDE1 RHOC IPO9 RUVBL1 MTUS1 CAPRIN1 RPL5 | 6.39e-04 | 639 | 143 | 13 | int:FBL |
| Interaction | DDX18 interactions | 6.47e-04 | 334 | 143 | 9 | int:DDX18 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 CASTOR2 SPDYE18 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE21 SPDYE5 SPDYE14 | 1.07e-11 | 271 | 155 | 13 | chr7q11 |
| Cytoband | 7q11.23 | 4.35e-08 | 97 | 155 | 7 | 7q11.23 | |
| Cytoband | 6q12-q13 | 1.13e-04 | 5 | 155 | 2 | 6q12-q13 | |
| Cytoband | Xq13.1 | 5.84e-04 | 48 | 155 | 3 | Xq13.1 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 3.81e-05 | 12 | 103 | 3 | 756 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.38e-04 | 18 | 103 | 3 | 596 | |
| GeneFamily | Rho family GTPases | 1.91e-04 | 20 | 103 | 3 | 390 | |
| GeneFamily | AAA ATPases | 2.35e-04 | 53 | 103 | 4 | 413 | |
| GeneFamily | Desmosomal cadherins | 6.63e-04 | 7 | 103 | 2 | 1188 | |
| GeneFamily | Immunoglobulin like domain containing | 8.30e-04 | 193 | 103 | 6 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.86e-03 | 394 | 103 | 8 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 2.22e-03 | 160 | 103 | 5 | 555 | |
| GeneFamily | ATPase phospholipid transporting | 3.22e-03 | 15 | 103 | 2 | 1210 | |
| GeneFamily | Cadherin related | 4.13e-03 | 17 | 103 | 2 | 24 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.13e-03 | 17 | 103 | 2 | 104 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP | 5.42e-06 | 21 | 148 | 4 | M41201 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-07 | 175 | 150 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-07 | 177 | 150 | 8 | a25ca82c4bda033ee113f8ecb4a541b22e7a29ca | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-07 | 177 | 150 | 8 | fbead6e56271b1f1d447f89857de444ebe7157b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-07 | 178 | 150 | 8 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.54e-07 | 188 | 150 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-07 | 190 | 150 | 8 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 2.86e-07 | 191 | 150 | 8 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.10e-07 | 193 | 150 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.10e-07 | 193 | 150 | 8 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19_Severe-B_intermediate|COVID-19_Severe / disease group, cell group and cell class | 3.22e-07 | 194 | 150 | 8 | 3418308da7f1278ae2bf3fb61fc361b222e30043 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-07 | 194 | 150 | 8 | 84aa5ca0356a06fce8799eb1bfa1c362bab34032 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 3.35e-07 | 195 | 150 | 8 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.59e-07 | 152 | 150 | 7 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 160 | 150 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 160 | 150 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 168 | 150 | 7 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.96e-06 | 172 | 150 | 7 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-06 | 178 | 150 | 7 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-06 | 178 | 150 | 7 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-06 | 183 | 150 | 7 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-06 | 185 | 150 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.29e-06 | 186 | 150 | 7 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.54e-06 | 188 | 150 | 7 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.54e-06 | 188 | 150 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 188 | 150 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.66e-06 | 189 | 150 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 3.79e-06 | 190 | 150 | 7 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | ILEUM-inflamed-(2)_B_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.92e-06 | 191 | 150 | 7 | 0aa913678456b7d525bd177588f2463f6ed76cd7 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-06 | 191 | 150 | 7 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.92e-06 | 191 | 150 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-06 | 192 | 150 | 7 | 432d07afedd872e81445a61bb64a382d110b723f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.06e-06 | 192 | 150 | 7 | 0bda96d8f223e8fa9caf935079ab202fc5c812ee | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | tumor_Lung-B_lymphocytes-Follicular_B_cells|tumor_Lung / Location, Cell class and cell subclass | 4.20e-06 | 193 | 150 | 7 | d0cb4bfc11491c903cb4cc0f823dd1ee239cf5c4 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Follicular_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.35e-06 | 194 | 150 | 7 | 05453f8c4d7f742b41d647d574a28555bf78ae39 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 194 | 150 | 7 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-06 | 194 | 150 | 7 | b700381f8337b4c6aa50d09ab5bfcd59f2fb2cf3 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.50e-06 | 195 | 150 | 7 | 820250198c787223eb4e073db11a983851ddcdd2 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.50e-06 | 195 | 150 | 7 | 2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 4.50e-06 | 195 | 150 | 7 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.65e-06 | 196 | 150 | 7 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | mild_COVID-19-B_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.65e-06 | 196 | 150 | 7 | 00398079d3ac14dc2026c0cbd7388f1f3257b134 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 196 | 150 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | severe-Lymphocytic-B_cells_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.65e-06 | 196 | 150 | 7 | 07651cac8a17c18dfa4e9c20cbf699fee2146145 | |
| ToppCell | severe_COVID-19-B_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.65e-06 | 196 | 150 | 7 | 1a2b7c3f00098e9b4c0659b8714a0e4cf9f86f27 | |
| ToppCell | 10x5'-lymph-node_spleen|World / Manually curated celltypes from each tissue | 4.65e-06 | 196 | 150 | 7 | 2951be22ab9095c4d3286c69dc4ab3308287c145 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 196 | 150 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.81e-06 | 197 | 150 | 7 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.81e-06 | 197 | 150 | 7 | e9327b133dab5f6a187cd8713f07205c948ec600 | |
| ToppCell | mild_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 4.81e-06 | 197 | 150 | 7 | b817ecdcea453a15fd0dd1d7fdf196bed68f7358 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.97e-06 | 198 | 150 | 7 | 6231c44a909dd06f85c8210814e976a5f29148d0 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.14e-06 | 199 | 150 | 7 | 38747e07853f60d11eda9371cf5e6493e21a9cc3 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.14e-06 | 199 | 150 | 7 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 200 | 150 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-05 | 152 | 150 | 6 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-05 | 156 | 150 | 6 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-05 | 160 | 150 | 6 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.73e-05 | 160 | 150 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 161 | 150 | 6 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 161 | 150 | 6 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.79e-05 | 161 | 150 | 6 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 161 | 150 | 6 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.92e-05 | 163 | 150 | 6 | f21951e63188eb0c04675a8f81a0da495c26c007 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.98e-05 | 164 | 150 | 6 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-05 | 168 | 150 | 6 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 169 | 150 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LAM-Lymphoid-B-cell-1|LAM / Condition, Lineage and Cell class | 2.43e-05 | 170 | 150 | 6 | 2b822a95a8d7ee193d40231418d6bd4cf9662842 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-05 | 170 | 150 | 6 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-05 | 173 | 150 | 6 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-05 | 173 | 150 | 6 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 174 | 150 | 6 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-05 | 174 | 150 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.86e-05 | 175 | 150 | 6 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.86e-05 | 175 | 150 | 6 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-05 | 176 | 150 | 6 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 176 | 150 | 6 | 27c132e9852717cbc345af7a1fc390e9ea589416 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 176 | 150 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 176 | 150 | 6 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-05 | 176 | 150 | 6 | 259d1864fb0a6d2feddc90bc715e2bccbb373792 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 177 | 150 | 6 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | 390C-Lymphocytic-B_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 178 | 150 | 6 | 02cb514096435a4d8c84f0cc12ae627db319621d | |
| ToppCell | 390C-Lymphocytic-B_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 178 | 150 | 6 | 9af29e341087ba4dd3ef246cdbae6469ea9de15f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-05 | 178 | 150 | 6 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.15e-05 | 178 | 150 | 6 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-05 | 179 | 150 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 179 | 150 | 6 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 180 | 150 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 180 | 150 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-05 | 180 | 150 | 6 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-05 | 180 | 150 | 6 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-05 | 181 | 150 | 6 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-05 | 181 | 150 | 6 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|normal_Lung / Location, Cell class and cell subclass | 3.56e-05 | 182 | 150 | 6 | 13c39228f76495deca6b948483bbde426b3e8c5b | |
| Disease | ulcerative colitis (implicated_via_orthology) | 3.85e-06 | 7 | 143 | 3 | DOID:8577 (implicated_via_orthology) | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 6.13e-06 | 8 | 143 | 3 | DOID:0080377 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 7.80e-05 | 145 | 143 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Anhydrotic Ectodermal Dysplasias | 1.39e-04 | 4 | 143 | 2 | C1706004 | |
| Disease | interleukin-6 measurement | 2.21e-04 | 112 | 143 | 5 | EFO_0004810 | |
| Disease | Hidrotic Ectodermal Dysplasia | 2.31e-04 | 5 | 143 | 2 | C0162361 | |
| Disease | breast cancer (is_marker_for) | 2.94e-04 | 185 | 143 | 6 | DOID:1612 (is_marker_for) | |
| Disease | ovarian carcinoma (is_marker_for) | 3.34e-04 | 28 | 143 | 3 | DOID:4001 (is_marker_for) | |
| Disease | Ectodermal Dysplasia | 3.45e-04 | 6 | 143 | 2 | C0013575 | |
| Disease | Aplasia Cutis Congenita | 3.45e-04 | 6 | 143 | 2 | C0282160 | |
| Disease | endometrial cancer (implicated_via_orthology) | 6.41e-04 | 8 | 143 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | PR interval | 7.18e-04 | 495 | 143 | 9 | EFO_0004462 | |
| Disease | urticaria, response to non-steroidal anti-inflammatory, angioedema | 8.21e-04 | 9 | 143 | 2 | EFO_0005531, EFO_0005532, EFO_0005533 | |
| Disease | multiple sclerosis, chronic lymphocytic leukemia | 8.21e-04 | 9 | 143 | 2 | EFO_0000095, MONDO_0005301 | |
| Disease | Cleft upper lip | 8.96e-04 | 39 | 143 | 3 | C0008924 | |
| Disease | autistic disorder (is_implicated_in) | 1.11e-03 | 42 | 143 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Leukoencephalopathy | 1.25e-03 | 11 | 143 | 2 | C0270612 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 1.49e-03 | 12 | 143 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.56e-03 | 447 | 143 | 8 | C3714756 | |
| Disease | X-11444 measurement | 1.76e-03 | 13 | 143 | 2 | EFO_0021237 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.85e-03 | 50 | 143 | 3 | EFO_0022247 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 2.04e-03 | 14 | 143 | 2 | C1858991 | |
| Disease | serum albumin measurement | 2.46e-03 | 592 | 143 | 9 | EFO_0004535 | |
| Disease | Astrocytosis | 3.02e-03 | 17 | 143 | 2 | C3887640 | |
| Disease | Gliosis | 3.02e-03 | 17 | 143 | 2 | C0017639 | |
| Disease | peak expiratory flow | 3.04e-03 | 498 | 143 | 8 | EFO_0009718 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.12e-03 | 60 | 143 | 3 | EFO_0022233 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 3.23e-03 | 295 | 143 | 6 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | calcium measurement | 3.62e-03 | 628 | 143 | 9 | EFO_0004838 | |
| Disease | age at menopause | 3.63e-03 | 302 | 143 | 6 | EFO_0004704 | |
| Disease | testosterone measurement | DCHS2 MAP1A NHSL2 NPEPPS CAST RREB1 BIRC6 C3P1 ZFHX4 ZIC5 MACF1 MME BANK1 KPNA2 | 3.68e-03 | 1275 | 143 | 14 | EFO_0004908 |
| Disease | Stomach Carcinoma | 4.61e-03 | 21 | 143 | 2 | C0699791 | |
| Disease | DNA methylation | 4.81e-03 | 656 | 143 | 9 | GO_0006306 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EISTEQEPEDYISVI | 136 | Q8NDB2 | |
| LESEEEEYPGITAED | 206 | Q9BXK5 | |
| TETPEDYTIIVDEEG | 56 | Q8NAP1 | |
| SQVVGPVQEEEYVAE | 251 | Q92667 | |
| EDTGVIYPSVEDSQE | 236 | O75143 | |
| TIEQSGELVYEAPET | 4121 | Q9NR09 | |
| PQEYAEGSVEETKEE | 1896 | Q68DQ2 | |
| SPEDSEGQDYVETVI | 551 | Q9P2K8 | |
| YSVVNTAEPDADEEE | 336 | Q9H8M2 | |
| EESQYGEVAEETPAS | 431 | Q6L9W6 | |
| EGENRVPVVYIAESD | 236 | Q9Y4W6 | |
| YTEVVTEFGTEVEPE | 1086 | Q8IUX7 | |
| FQVDEIYTVPEVGTV | 411 | Q9BX10 | |
| DSLNIPDVDEEGYSI | 311 | Q0JRZ9 | |
| ETPEDYTIIVDEEGF | 46 | A6NHX0 | |
| YTPEDVEGNVQLETG | 141 | O75534 | |
| EEQAVYEPLENEGIE | 261 | Q12797 | |
| YEPLENEGIEITEVT | 266 | Q12797 | |
| ADDDGEITYENVQVP | 31 | P21854 | |
| ETEEEEEPYGLQVAR | 2726 | Q96M86 | |
| SYDVTTLQDEEGELP | 406 | Q8TF21 | |
| ENVGDYEPSAQEEVL | 1201 | Q9UPW5 | |
| EPEPAEEYTEQSEVE | 276 | Q14444 | |
| VYVEDINDEAPVFTQ | 1196 | Q9H251 | |
| SYQEAVFEDVPVGTI | 2406 | Q9H251 | |
| YQEADSEEEEVVPRG | 461 | O60312 | |
| GLNDDYVFVTPVEVD | 56 | Q8TE60 | |
| EEGENLEAEIVYPIT | 81 | Q9UKD1 | |
| SDPEQGVEVTGQYER | 761 | Q14624 | |
| DEDDIGIYISEIDPN | 441 | Q9UPQ7 | |
| EDTGIYVSEVDPNSI | 426 | Q6ZMN7 | |
| GEIEFEVVYVAPEVD | 361 | Q9HD26 | |
| EVVYVAPEVDSDDEN | 366 | Q9HD26 | |
| DQPYANEGTVVVTER | 976 | Q14126 | |
| DNTDVEPFVVDGRVY | 411 | Q8IZ02 | |
| EGQEAADRDEVYTIP | 276 | O75121 | |
| DPDTEDAQLVYEITT | 2471 | Q86XX4 | |
| AVYSSQGSEAEEEEP | 221 | Q9HBG6 | |
| EVAPNDVVSEVGIFY | 696 | Q8NG48 | |
| QDETIPGYSETEQTI | 736 | P78559 | |
| PGYSETEQTISDEEI | 741 | P78559 | |
| EVGIETDEDYNVTLP | 201 | Q9P2W1 | |
| EEDTEDGVSFQPYIE | 331 | Q8IU57 | |
| NEEIVSDPIYIEVQG | 181 | Q12866 | |
| VDYETDPAVVTGENI | 56 | Q9ULD2 | |
| PEGPEDQAVTEYVAT | 166 | Q8TD08 | |
| VDVEEAVLGQYTEEP | 976 | P52732 | |
| EVTPSDDEGLSVVEY | 716 | Q5JUK3 | |
| ETQEEETNSGEEPFI | 56 | Q14457 | |
| EDITGDTYGPVTEDQ | 606 | Q86SJ6 | |
| SVPQDEVDEIEVYGS | 436 | Q10570 | |
| EQEELVYTAEGEEIP | 246 | Q96I76 | |
| SVQGDEVTLYTPEER | 166 | Q06265 | |
| PSQVEVPEDEEDYTA | 666 | P29122 | |
| TPGQVYDVEEVDVKD | 126 | Q53EL6 | |
| YGKVENPLDTEVEES | 761 | Q9UHC1 | |
| ISITNEEDVVVYAPE | 336 | P08473 | |
| ATESGDEVPVELYTA | 191 | Q8IZD2 | |
| TDVTSGPEVEVLYES | 661 | O94854 | |
| RNSGYDTEPEIIEET | 1501 | Q6ZVL6 | |
| EVIGTDESQEVPYTI | 981 | P98088 | |
| QEYVVVEAEEELTPS | 166 | Q07075 | |
| PVYESNGVTDQAEAE | 471 | O75110 | |
| AELSAPDIEGVYETQ | 1416 | Q07864 | |
| GVDNSEDPVYESLEE | 291 | Q8TE49 | |
| DIITASYAPEGDEEI | 101 | A6NEC2 | |
| EEEEENEPESLGVVY | 86 | O15541 | |
| GSIYNPEVLDITEET | 196 | P05388 | |
| APVYQQEEIAEGAVT | 316 | O00222 | |
| AEPAETNGEITAYEV | 1241 | P16144 | |
| SDEEQSVVYVPGISA | 21 | Q86T90 | |
| PEEYNETDQGIAETE | 281 | Q9BXL5 | |
| YGPIQVEFVSADIDE | 1296 | O14522 | |
| VSSYDIEVLENQEPE | 1831 | Q6V1P9 | |
| EGVSTPEYTSCEDVE | 536 | Q86UR5 | |
| EEDQNVVPETTSEGY | 501 | P52292 | |
| LERSPVDESGDEVQY | 976 | Q8WX93 | |
| VDESGDEVQYGDVPV | 981 | Q8WX93 | |
| QLEYSVPEETERGVA | 21 | Q9H158 | |
| EIDSEPGVENVFEVS | 1121 | Q8NFC6 | |
| SEQGPYGEIISEEQE | 651 | A4FU69 | |
| AQTEPTVEVEEFVYD | 646 | Q96BY6 | |
| VPDTEAEVFISVQGY | 156 | Q6ZMU1 | |
| SYDEVEESVPVIGQL | 96 | Q99715 | |
| PETEYVVNVYSVVED | 1446 | Q99715 | |
| VVNVYSVVEDEYSEP | 1451 | Q99715 | |
| AEYEIPSVRESDAEQ | 166 | Q96LA6 | |
| TVTIVYSGEDEPQLA | 791 | Q9UQ52 | |
| AVYDEQGTVDEDSPV | 76 | Q8WXX5 | |
| QEQYEDVSITEGSPL | 286 | Q8IY85 | |
| EEENTTYTGPEVSDP | 171 | P20810 | |
| VTPYVTEVESVVGEN | 586 | Q9HBG7 | |
| NYTEEVEDPVDSDGE | 311 | Q96P70 | |
| AYTAEQENEPTVGVI | 101 | O95239 | |
| EELQPVYVNVGSVDV | 456 | Q96LA5 | |
| EYPFVEDVGTEIETA | 336 | P51170 | |
| YEIEIFGEPATVAEQ | 1206 | O75923 | |
| IAETIDVNYSDVVPG | 476 | O94829 | |
| DIITASYAPEGDEEI | 101 | P55786 | |
| GQIVETYTEEDPEGA | 106 | O60716 | |
| NVYVPSTEPEEEGEA | 536 | Q13029 | |
| STEPEEEGEADDVYI | 541 | Q13029 | |
| PTVFENYIADIEVDG | 36 | P08134 | |
| TVEIVDPGDESTVYI | 1876 | P0C091 | |
| ETYGEVEEEPLDEAQ | 446 | Q5HYW3 | |
| PTVFENYVADIEVDG | 36 | P61586 | |
| PTVFENYVADIEVDG | 36 | P62745 | |
| ITVETEFDNPIYETG | 1001 | Q9BYH1 | |
| VSDVENYVGPERSVD | 146 | O75151 | |
| GQESESIPEYTAEEE | 2861 | Q8WUY3 | |
| NGVDPEEVVEQYGID | 646 | Q15031 | |
| VPTDSGTTDVDYDEE | 501 | Q5HYW2 | |
| QDPVTYISETDEEDD | 101 | P35251 | |
| VTQEEERDGQYFEPV | 1316 | P0DJD1 | |
| AEDDVVTPGTSEDRY | 46 | Q86YL7 | |
| EIADPTYEVGIEELQ | 351 | Q5VWT5 | |
| EEEDPYQGTIVLATV | 766 | Q99707 | |
| GGEEEVEQVPAETLY | 496 | Q5VSL9 | |
| TSGYPLQEVVDDEVS | 26 | P0DUX0 | |
| TSGYPLQEVVDDEVS | 26 | P0DTA3 | |
| TSGYPLQEVVDDEVS | 26 | P0DUD1 | |
| GQVEVTGDEYNVESI | 121 | P46777 | |
| EEIYEESQQVFLAPG | 1016 | Q9Y2G9 | |
| VYSLDSVEEAETEQP | 411 | Q8TE82 | |
| IEDDIIYTQDFTVPG | 356 | Q15831 | |
| PTVYVGTAVNLEEDE | 596 | Q9UHV7 | |
| KEEEQATETQPIVYG | 1621 | Q00610 | |
| SQEYVASEGEEDPEV | 196 | Q86X95 | |
| ESEEEYNDEGEVVPR | 11 | Q7KZ85 | |
| HQYVQETVIDTPEDE | 166 | A4UGR9 | |
| VIPYDGDQSVVDASE | 61 | Q5SV17 | |
| DSPAADVEIEYVTEE | 361 | Q13435 | |
| VETPVSYVGEDDEED | 386 | Q14186 | |
| DSDVENLTGEIVYQP | 121 | Q86UP3 | |
| EPQGVVYEDVPDDTE | 16 | O75762 | |
| DEYEVSSDPEANIVI | 706 | Q9UPR6 | |
| YIDSEIGTSDQIVPE | 346 | Q96RU8 | |
| IGTSDQIVPEYQEDS | 351 | Q96RU8 | |
| TEAAQAPEVTYEAEE | 196 | Q96DV4 | |
| VPEQDIESYVLAADG | 816 | Q92766 | |
| TSGYPLQEVVDDEVS | 26 | P0DUX1 | |
| TSGYPLQEVVDDEVL | 26 | A0A494C0Z2 | |
| TSGYPLQEVVDDEVL | 26 | P0DUD3 | |
| TSGYPLQEVVDDEVL | 26 | P0DUD4 | |
| TSGYPLQEVVDDEVS | 26 | P0DUD2 | |
| TSGYPLQEVVDDEVL | 36 | P0DV79 | |
| TSGYPLQEVVDDEVL | 36 | A0A494C086 | |
| TSGYPLQEVVDDEVL | 36 | A6NIY4 | |
| EVDERPTEQYSDIGG | 176 | P17980 | |
| EVPYVEENGRAEETE | 36 | A6NMA1 | |
| SQQEGSGDYEVEEIP | 41 | Q9H5H4 | |
| EEEQEVYEVSVPGDD | 116 | Q8N1W2 | |
| YEGEVTELTPCETEN | 131 | Q9Y265 | |
| DSIPSEVDYETRQGV | 1221 | Q9UPU5 | |
| EITTAEPQVSEAVYD | 1221 | Q6ZT12 | |
| EISENYAGDVSQVPE | 91 | P17020 | |
| TSGYPLQEVVDDEVS | 26 | A0A494C191 | |
| DNVSVYPSVSEEPVE | 1341 | Q5VWN6 | |
| IDTQGVPYTVLVDEE | 56 | Q9P0T4 | |
| VTKTHDQPVEEEDGY | 516 | Q5QJ38 | |
| EVYGPEVETIVQEED | 71 | Q15029 | |
| EVEGKTPEEVIEYSA | 871 | O60264 | |
| VDEQEETVISYESTP | 1061 | Q9HAU0 | |
| ETEDEEIYGNPEVVR | 646 | Q96T25 | |
| FEYVRQETGIDDIPD | 351 | Q8TDW0 | |
| LNVQYEPEVTIEGFD | 241 | Q15223 |